Stockscreener 앱 받기
52.95
2.55%
1.26
전일 마감가:
$51.69
열려 있는:
$56.75
하루 거래량:
160.18K
Relative Volume:
2.88
시가총액:
$72.73M
수익:
$697.00K
순이익/손실:
$-38.97M
주가수익비율:
-1.8212
EPS:
-29.075
순현금흐름:
$-33.33M
1주 성능:
-23.53%
1개월 성능:
-9.23%
6개월 성능:
-62.28%
1년 성능:
-90.34%
1일 변동 폭
$52.01
$56.75
1주일 범위
$51.36
$74.00
52주 변동 폭
$7.26
$543.38
스프루스 바이오 Stock (SPRB) Company Profile
명칭
Spruce Biosciences Inc
전화
(415) 655-4168
주소
611 GATEWAY BOULEVARD, SUITE 740, SOUTH SAN FRANCISCO
Compare SPRB vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SPRB
Spruce Biosciences Inc
|
53.00 | 70.93M | 697.00K | -38.97M | -33.33M | -29.07 |
VRTX
Vertex Pharmaceuticals Inc
|
436.83 | 111.05B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
742.73 | 79.01B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
793.73 | 50.08B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
310.76 | 41.15B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
309.88 | 34.67B | 5.36B | 287.73M | 924.18M | 2.5229 |
스프루스 바이오 Stock (SPRB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-23 | 개시 | Oppenheimer | Outperform |
| 2025-12-03 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2025-10-28 | 업그레이드 | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2024-12-11 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-12-11 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2024-03-14 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2024-03-14 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2024-03-14 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2024-03-14 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-03-14 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-02-21 | 개시 | Guggenheim | Buy |
| 2021-12-17 | 개시 | Oppenheimer | Outperform |
| 2021-12-10 | 개시 | The Benchmark Company | Speculative Buy |
| 2021-11-16 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2021-07-19 | 개시 | H.C. Wainwright | Buy |
| 2021-04-26 | 재개 | Credit Suisse | Outperform |
| 2020-11-03 | 개시 | Cowen | Outperform |
| 2020-11-03 | 개시 | Credit Suisse | Outperform |
| 2020-11-03 | 개시 | RBC Capital Mkts | Outperform |
| 2020-11-03 | 개시 | SVB Leerink | Outperform |
모두보기
스프루스 바이오 주식(SPRB)의 최신 뉴스
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
SPRB Spruce Biosciences Inc. gains 3.53 percent even as Q4 2025 earnings miss analyst consensus estimates.Recovery Report - Xã Thanh Hà
Spruce Biosciences Prices Equity Offering to Raise Capital - TipRanks
Spruce Biosciences Enters Underwriting For $69 Million Equity Offering; Option Fully Exercised - TradingView
Spruce Biosciences prices $60M public offering at $50.00 per share - MSN
Spruce Biosciences (NASDAQ: SPRB) raises about $69.0 million in equity sale - Stock Titan
Spruce Biosciences (NASDAQ: SPRB) sells 1.15M shares, issues pre-funded warrants - Stock Titan
Why is Spruce Biosciences stock sinking Tuesday? - MSN
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Spruce Biosciences (SPRB) and AXT (AXTI) Stocks Decline Followin - GuruFocus
SPRB: New Offering Managed by Leading Investment Firms - GuruFocus
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Why Is Spruce Biosciences Stock Sinking Tuesday? - Benzinga
Morning Market Movers: LOCL, CLIK, SPRC, SPRB See Big Swings - RTTNews
Spruce Biosciences prices $60M public offering at $50 per share By Investing.com - Investing.com South Africa
Stock Market Today: Dow Jones, S&P 500 Futures Edge Higher With Eyes On Iran Talks—Apple, UnitedHealth, 3M In Focus - Benzinga
Why Amazon Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga
Spruce Biosciences locks in $60M raise at $50 a share - Stock Titan
Spruce Biosciences Prices Public Offering of Common Stock, Prefunded Warrants>SPRB - Moomoo
Spruce Biosciences (SPRB) Announces $60 Million Public Offering - GuruFocus
Spruce Biosciences Offering Expected to Close April 22 >SPRB - Moomoo
Spruce Biosciences launches public stock offering By Investing.com - Investing.com India
Spruce Biosciences Expects Gross Proceeds of $60M >SPRB - Moomoo
Spruce Biosciences prices $60M public offering at $50 per share - Investing.com Canada
Spruce Biosciences Announces Pricing Of Public Offering Of Common Stock And Pre-Funded Warrants - TradingView
Spruce Biosciences Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants - Business Wire
Spruce Biosciences Begins Public Offering of Stock, Prefunded Warrants; Shares Fall After Hours - Moomoo
Spruce Biosciences Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants - The National Law Review
Spruce Biosciences announces proposed public offering of common stock, pre-funded warrants - MSN
Spruce Biosciences (SPRB) Sees 13% Drop Following Equity Offerin - GuruFocus
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Spruce Biosciences launches public stock offering - Investing.com
Spruce Biosciences Announces Proposed Public Offering Of Common Stock And Pre-Funded Warrants - TradingView
Spruce Biosciences (SPRB) seeks capital with common stock and pre-funded warrants offering - Stock Titan
SPRB Technical Analysis | Trend, Signals & Chart Patterns | SPRUCE BIOSCIENCES INC (NASDAQ:SPRB) - ChartMill
Top Anthem (ANTX) Competitors 2026 - MarketBeat
SPRB Stock Price, Quote & Chart | SPRUCE BIOSCIENCES INC (NASDAQ:SPRB) - ChartMill
Spruce Biosciences (NASDAQ: SPRB) sets 2026 virtual meeting and pay votes - Stock Titan
SPRB SEC FilingsSpruce Biosciences, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Spruce Biosciences, Inc. (SPRB) stock price, news, quote and history - Yahoo Finance UK
Wall Street experts predict that Spruce Biosciences (SPRB) may surge by 181.21%: Strategies for Trading - Bitget
Wall Street Analysts Believe Spruce Biosciences (SPRB) Could Rally 181.21%: Here's is How to Trade - Yahoo Finance
SPRB Earnings History & Surprises | EPS & Revenue Results | SPRUCE BIOSCIENCES INC (NASDAQ:SPRB) - ChartMill
SPRB Forecast, Price Target & Analyst Ratings | SPRUCE BIOSCIENCES INC (NASDAQ:SPRB) - ChartMill
Leerink Partners Maintains Spruce Biosciences (SPRB) Market Perform Recommendation - MSN
Spruce Biosciences, Inc. (NASDAQ:SPRB) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Spruce Stock Ignites: A 24% Surge Defies Gravity as Energy Winds Shift - Bitget
Citizens reiterates Spruce Biosciences stock rating on approval outlook - Investing.com
Citizens reiterates Spruce Biosciences stock rating on approval outlook By Investing.com - Investing.com India
스프루스 바이오 (SPRB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
스프루스 바이오 주식 (SPRB) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Gharib Samir M. | PRESIDENT AND CFO |
Dec 15 '25 |
Option Exercise |
0.00 |
1,009 |
0 |
8,447 |
| Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER |
Dec 15 '25 |
Option Exercise |
0.00 |
2,676 |
0 |
14,922 |
| Gharib Samir M. | PRESIDENT AND CFO |
Dec 11 '25 |
Option Exercise |
0.00 |
1,900 |
0 |
8,296 |
| Gharib Samir M. | PRESIDENT AND CFO |
Dec 10 '25 |
Option Exercise |
0.00 |
514 |
0 |
6,580 |
| Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER |
Dec 11 '25 |
Option Exercise |
0.00 |
4,950 |
0 |
15,192 |
| Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER |
Dec 10 '25 |
Option Exercise |
0.00 |
1,196 |
0 |
10,670 |
| Gharib Samir M. | PRESIDENT AND CFO |
Oct 20 '25 |
Option Exercise |
0.00 |
2,053 |
0 |
6,727 |
| Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER |
Oct 20 '25 |
Option Exercise |
0.00 |
4,784 |
0 |
11,013 |
| Parkman Healthcare Partners LL | 10% Owner |
Oct 06 '25 |
Buy |
17.91 |
256 |
4,585 |
1,307 |
| Parkman Healthcare Partners LL | 10% Owner |
Oct 06 '25 |
Sale |
19.14 |
257 |
4,920 |
1,050 |
1.09%
0.42%
자본화:
|
볼륨(24시간):